First-line sunitinib cost-effective alternative to interferon-α in renal cancer Clinical study 13 February 2013 Pages: 1 - 1
Cost studies still not being used at all levels of decision-making Comment 13 February 2013 Pages: 2 - 2
Inappropriate therapy for MRSA costly, potentially deadly, problem Clinical study 13 February 2013 Pages: 5 - 5
Empirical aciclovir cost effective for some neonatal HSV cases Clinical study 13 February 2013 Pages: 5 - 5
Improved oxygen systems decrease mortality in childhood pneumonia News item 13 February 2013 Pages: 6 - 6
Drug warnings fail to decrease antipsychotic use in elderly Media release 13 February 2013 Pages: 6 - 6
Modified guidelines prove effective in childhood pneumonia Clinical study 13 February 2013 Pages: 7 - 7
Only a fraction of patients with diabetes mellitus undergoing PCI* for NSTE-ACS** in Europe receive GPIIb-IIIa antagonists, Clinical study 13 February 2013 Pages: 7 - 7
The combination of two existing, inexpensive drugs may offer new hope News item 13 February 2013 Pages: 8 - 8
The under-use of Β-blockers for treating chronic heart failure (HF) might be explained by the deteriorations associated with advanced disease. Clinical study 13 February 2013 Pages: 8 - 8
More employers are looking to consumer-driven health plans and employee wellness programmes Media release 13 February 2013 Pages: 8 - 8
California's tobacco control programme saved $US86 billion (2004 values) in personal healthcare costs Media release 13 February 2013 Pages: 8 - 8
Previous studies have demonstrated the reliability of the Psoriatic Arthritis Quality of Life tool (PsAQoL) Clinical study 13 February 2013 Pages: 9 - 9
Bayer Schering, Germany, has announced it will support the US Agency for International Development (USAID) Media release 13 February 2013 Pages: 10 - 10
Novartis has announced that the final National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Guidance Media release 13 February 2013 Pages: 10 - 10
Decision Resources has forecast that the hepatitis B drug market in China will more than double by 2012, Media release 13 February 2013 Pages: 10 - 10
Medical bills and debts are affecting 79 million adults in the US, Media release 13 February 2013 Pages: 10 - 10
Lidocaine 5% medicated plaster [Versatis] has been approved for restricted use within the NHS Scotland Media release 13 February 2013 Pages: 10 - 10
Russia will enter the top 10 global pharmaceutical markets in 2008, News item 13 February 2013 Pages: 11 - 11
Sharing of prescription medications is common practice among over one-third of women of reproductive age, Media release 13 February 2013 Pages: 11 - 11